ESPR in the 13F filings

Esperion Therapeutics Inc · CUSIP 29664W105

Quarter end
30 Sep 2024
the date the book describes
Filed
14 Nov 2024
latest of these filings; the earliest 14 Nov 2024
Managers listing it
2
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q2 2024 and Q3 2024; 2 listed it in both
Shares listed
2,466,842
combined, among listed positions
Reported value
$4.1m
combined, at the quarter end

Among the 94 comparable managers: 0 buyers (opened or added shares) and 1 seller (trimmed or exited), at least, among listed positions. Their net change in shares was -2,805,448.

Managers listing ESPR in Q3 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

2 of 2 holders

ActionFiling
Woodline Partners LP2,244,360$3.7munder 0.1%Trimmed-2,805,44814 Nov 2024 (the filing on sec.gov)
Davidson Kempner Capital Management LP222,482$367kunder 0.1%Held014 Nov 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q2 2024 to Q3 2024, among managers that listed it in both quarters or opened it.

Increases

No increase among listed positions.

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
2 in Q2 2024 to 1 in Q2 2026

Tracked managers listing it, at least.

024620152016201720182019202020212022202320242025
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
ESPR by quarter
QuarterHoldersReported valueBuyersSellers
Q1 20154$36mn.a.n.a.
Q2 20154$142mn.a.n.a.
Q3 20152$17mn.a.n.a.
Q4 20151$15mn.a.n.a.
Q1 20162$14mn.a.n.a.
Q2 20161$10mn.a.n.a.
Q3 20163$15mn.a.n.a.
Q4 20162$14mn.a.n.a.
Q1 20173$27mn.a.n.a.
Q2 20172$49mn.a.n.a.
Q3 20175$68mn.a.n.a.
Q4 20173$62mn.a.n.a.
Q1 20181$14mn.a.n.a.
Q2 20182$23mn.a.n.a.
Q3 20181$23mn.a.n.a.
Q1 20191$8.7mn.a.n.a.
Q2 20192$11mn.a.n.a.
Q3 20193$24mn.a.n.a.
Q4 20193$36mn.a.n.a.
Q1 20203$53mn.a.n.a.
Q2 20202$71mn.a.n.a.
Q3 20201$51mn.a.n.a.
Q4 20201$36mn.a.n.a.
Q1 20212$47mn.a.n.a.
Q2 20213$28mn.a.n.a.
Q3 20212$2.1mn.a.n.a.
Q4 20211$1.2mn.a.n.a.
Q1 20222$2.2mn.a.n.a.
Q2 20223$11mn.a.n.a.
Q3 20223$31mn.a.n.a.
Q4 20226$49mn.a.n.a.
Q1 20231$354kn.a.n.a.
Q2 20231$309kn.a.n.a.
Q3 20231$219kn.a.n.a.
Q4 20232$1.5m10
Q1 20242$22m10
Q2 20242$12m01
Q3 20242$4.1m01
Q4 20241$489k00
Q1 20251$320k00
Q2 20251$219k00
Q3 20251$590k00
Q4 20252$13m1911
Q2 20261$2.4m1118

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

Choose a stock to compare with ESPR →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own ESPR, latest filings →Back to the 13F Explorer →